Related Experiment Video
Updated: May 8, 2025
09:40
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
ARL6IP5 in cancers: bidirectional function and therapeutic value
Zenan Hu1,2,3, Hanxun Yue1,2,3, Liang Qiao4
1The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
Cancer Gene Therapy
|April 19, 2025
Summary
ADP-ribosylation-like factor 6 interacting protein 5 (ARL6IP5) has a debated role in cancer. This review clarifies its function in hepatocellular carcinoma and potential therapeutic applications.
Area of Science:
- Oncology
- Molecular Biology
Background:
- ADP-ribosylation-like factor 6 interacting protein 5 (ARL6IP5) is implicated in various physiological and pathological processes.
- The specific roles of ARL6IP5 in cancer development and progression remain controversial.
- Hepatocellular carcinoma, particularly that related to chronic hepatitis virus, is a key focus.
Purpose of the Study:
- To review and synthesize current knowledge on ARL6IP5's involvement in cancer.
- To elucidate the function of ARL6IP5 in the context of chronic hepatitis virus-related hepatocellular carcinoma.
- To explore the potential of ARL6IP5 as a therapeutic target in cancer treatment.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of studies focusing on ARL6IP5's molecular mechanisms in cancer.
- Examination of clinical data and experimental findings related to ARL6IP5 and cancer.
Main Results:
- ARL6IP5 exhibits complex and context-dependent roles in different cancer types.
- Evidence suggests ARL6IP5 influences the progression of chronic hepatitis virus-related hepatocellular carcinoma.
- Understanding ARL6IP5's functions may reveal new therapeutic strategies.
Conclusions:
- ARL6IP5 is a significant factor in cancer biology with a complex role.
- Targeting ARL6IP5 may offer novel therapeutic avenues for hepatocellular carcinoma.
- Further research is needed to fully elucidate ARL6IP5's mechanisms and clinical utility.
Related Concept Videos
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:33Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
02:23Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
01:19Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
02:39lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K